Why the study?
While fully reduced HMGB1 promotes tissue repair, its oxidative conversion into disulfide form activates proinflammatory pathways via TLR-2, TLR-4, and RAGE.
An engineered HMGB1 construct (dBB12L) decouples regenerative and inflammatory functions, offering a potential therapeutic for tissue repair without deleterious inflammation.
Answers are grounded in this paper and cite their sources.
HMGB1 redox forms may differentially prime repair or drive inflammation; leaves open targeted modulation in cardiac injury.
Fully reduced High Mobility Group Box 1 (HMGB1) binds CXCL12 and signals via CXCR4 when released into the extracellular space. It acts as a chemokine and transitions stem cells from quiescent G₀ to a primed G Alert state. Cells in G Alert rapidly enter G 1 in response to activating factors released by tissue injury to promote tissue repair. However, oxidative conversion of FR-HMGB1 into the disulfide form activates proinflammatory pathways via TLR-2, TLR-4 and RAGE. Peptide mapping and NMR spectroscopy identified a conserved CXCL12-binding motif within each Box and adjacent flanking regions. We decoupled the regenerative and inflammatory functions using an engineered construct (dBB12L), comprising tandem Box B domains with a flexible linker. dBB12L exhibited CXCL12 binding and accelerated repair equivalent to FR-HMGB1. Importantly, dBB12L lacked detectable RAGE binding and did not signal via TLR-2 and TLR-4, establishing it as a potential therapeutic to promote tissue repair without deleterious inflammation.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: